Litcius/Paper detail

A combined in vitro in-silico approach to predict the oral bioavailability of borderline BCS Class II/IV weak base albendazole and its main metabolite albendazole sulfoxide

Maximo Pettarin, Michael B. Bolger, Maja Chronowska, Edmund Kostewicz

2020European Journal of Pharmaceutical Sciences19 citationsDOI

Topics & Concepts

Physiologically based pharmacokinetic modellingBioavailabilityChemistryPharmacokineticsAlbendazoleSolubilityPharmacologyChromatographyMetaboliteBiochemistryMedicineOrganic chemistrySurgeryDrug Transport and Resistance MechanismsLiver Disease and TransplantationHelminth infection and control
A combined in vitro in-silico approach to predict the oral bioavailability of borderline BCS Class II/IV weak base albendazole and its main metabolite albendazole sulfoxide | Litcius